Therapeutic Specialties Archives | Page 13 of 28 | Certara

Poster

Predicting Diclofenac Systemic and Synovial Fluid Concentrations After Dermal Application Using the Multi-phase Multi-layer MechDermA PBPK Model

CertaraJune 6, 2017

Publication

Time Dependent Pharmacokinetics of Pembrolizumab in Patients with Solid Tumor and Its Correlation with Best Overall Response

CertaraJune 1, 2017

On-Demand Webinar

Obeticholic Acid—From PK Model to Drug Label

Watch this webinar with Jeffrey Edwards to learn how he used physiologic pharmacokinetic modeling to…

CertaraJune 1, 2017

Publication

Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications

CertaraMay 1, 2017

Publication

Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats

CertaraMay 1, 2017

Publication

CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites

CertaraMarch 1, 2017

Publication

Clarification of Contraceptive Drug Pharmacokinetics in Obesity

CertaraJanuary 1, 2017

Publication

Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer

CertaraDecember 18, 2016

Publication

Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy

CertaraDecember 5, 2016

Publication

The Pharmacokinetics of Transdermal Flunixin Meglumine in Holstein Calves

This study describes the pharmacokinetics of topical and intravenous (IV) flunixin meglumine in Holstein calves.…

CertaraDecember 1, 2016

© 2025 Certara. All Rights Reserved. | Legal | Privacy policy